RECRUITING

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

Official Title

A Randomized Controlled Trial of a Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

Quick Facts

Study Start:2025-02-10
Study Completion:2029-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06929442

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18-30 years old
  2. 2. Enrolled as a first or second year student (i.e., freshman or sophomore) in an undergraduate program at the college or university where the intervention takes place
  3. 3. Students who endorse some psychotic experiences (Peter's et al. Delusion Inventory (PDI) score \> 3)
  1. 1. Inability to provide informed consent
  2. 2. Not proficient in English
  3. 3. Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization
  4. 4. Current enrollment in psychological or behavioral health treatment.
  5. 5. Current use of psychotropic medications (other than stimulants) prescribed by a physician.
  6. 6. A diagnosis of a serious, chronic mental illness as determined by the Mini-International Neuropsychiatric Interview (MINI)

Contacts and Locations

Study Contact

Daphne J Holt, MD, PhD
CONTACT
617-726-7618
dholt@mgh.harvard.edu

Study Locations (Sites)

Massachusetts General Hospital
Charlestown, Massachusetts, 02129
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-10
Study Completion Date2029-06

Study Record Updates

Study Start Date2025-02-10
Study Completion Date2029-06

Terms related to this study

Additional Relevant MeSH Terms

  • Psychotic Disorders
  • Mood Disorders
  • Anxiety Disorders